Corporate partners
Connetics is an independent specialty pharmaceutical company focused on the
development and commercialization of innovative therapeutics for the
dermatology market. Current marketed psoriasis products are OLUX® (clobetasol propionate) Foam, Luxiq® (betamethasone valerate), both topical steroids which may be used for mild, moderate and severe psoriasis, and newly obtained Soriatane® (acitretin), an oral retinoid used to treat moderate to severe psoriasis.
These formulations aim to improve the management of dermatological diseases and provide significant product differentiation, and have earned wide acceptance by both physicians and patients due to their clinical effectiveness, high quality and cosmetic elegance. For more information about Connetics and products, please visit: www.connetics.com
The link above takes you off the Psoriasis Foundation Web site. The Psoriasis Foundation does not endorse or accept any responsibility for the content of external Web sites. Click here for complete terms of use.
| 
